Proven Safety

Skip to main content
NeuroPace, Inc.
  • Patients
  • Providers
  • Corporate
  • PDMS
  • nSight
  • Take the Quiz
  • Product
    • The RNS System
    • nSight Platform
    • MRI Safety
    • DIXI US Products
  • Clinical Benefits
    • Seizure Reduction
    • Quality of Life
    • Proven Safety
  • Actionable Insights
    • Real World EEG Data
    • Monitor Patients Remotely
    • Assess Treatment Effects
    • Counsel Patients
  • Patient Selection
    • Neocortical
    • Mesial Temporal
  • Education
    • Webinars
    • RNS System Education
    • Fellows Education
    • Programming Resources
  • Clinical Trials
  • Resources
    • Publications
    • Physician Product Manuals
    • Reimbursement References
    • MRI Guidelines
  • Product
    • The RNS System
    • nSight Platform
    • MRI Safety
    • DIXI US Products
  • Clinical Benefits
    • Seizure Reduction
    • Quality of Life
    • Proven Safety
  • Actionable Insights
    • Real World EEG Data
    • Monitor Patients Remotely
    • Assess Treatment Effects
    • Counsel Patients
  • Patient Selection
    • Neocortical
    • Mesial Temporal
  • Education
    • Webinars
    • RNS System Education
    • Fellows Education
    • Programming Resources
  • Clinical Trials
  • Resources
    • Publications
    • Physician Product Manuals
    • Reimbursement References
    • MRI Guidelines
Press enter to begin your search

Proven Safety Profile

nine years prospective data badge

“Responsive neurostimulation was well tolerated and safe over time.”

Conclusions from 9 years of data in the largest prospective neuromodulation study in the field of epilepsy1

Neurology, 2020

Read More About the Long-Term Data

The RNS® System Has No Chronic Stimulation
Side Effects1

graphic of brain with blue dot

Side effects seen with DBS2,3:

  • Depression
  • Anxiety
  • Memory Impairment
  • Sleep Disruption
graphic of brain

Side effects seen with VNS4:

  • Voice alterations
  • Throat pain and cough
  • Shortness of breath
  • Difficulty swallowing
man smiling

“The RNS System basically functions in the background for me. As I go about my daily life, I do not feel any physical or mental sensations from its electrical signals.”

Michael

RNS System patient since 2014*

Read His Story

Lower SUDEP Rates with the RNS System

Each year, 1 in 150 people with uncontrolled seizures die from Sudden Unexpected Death in Epilepsy (SUDEP).5

Patients treated with the RNS System have a statistically significantly lower rate of SUDEP than a comparable refractory population.1

Read More About Lower SUDEP Rates

Graphic of a brain with arrow indicating lower SUDEP rates

1. Nair, et al., Neurology, 2020. 2. Sprengers et al., Cochrane Database of Systematic Reviews , 2017. 3. Voges et al., Epilepsia 2015; n=9 *N values are small and caution must be taken while interpreting results. 4. VNS Therapy® System Epilepsy Physician’s Manual, May 2020. 5. Tomson, T, et al., Lancet Neurology, 2008.

*Every individual’s seizures are different and results will vary.

More questions? Contact an RNS System Professional.

Send a message

  • Safety Information
  • Legal
  • Privacy Policy
1-866-726-387624-hr Support Line

PATIENTS

  • Drug-Resistant Epilepsy
  • The RNS System
  • Hear from Patients
  • Is It Right for You?
  • Current Patients
  • Resources

PROVIDERS

  • Product
  • Clinical Benefits
  • Actionable Insights
  • Patient Selection
  • Education & Training
  • Resources

ABOUT US

  • In The News
  • Press Releases
  • Leadership
  • Careers
  • Contact Us
  • FCOI Procedure
  • PATIENTS

    Safety
  • PROVIDERS

    Legal
  • INVESTORS

    Privacy Policy
  • ABOUT US

1-866-726-3876 24-hr Support Line

© 2026 NeuroPace, Inc..

Step 1 of 7

14%
    The RNS System is for individuals 18 and older who have focal epilepsy and have tried two or more medications without finding seizure control.
  • Based on your answers, your patient might benefit from the RNS System.

    Get your profile and a list of questions to ask your doctor.

  • Unfortunately it appears your patient is not an appropriate candidate for the RNS® System at this time.

  • The RNS® System is intended for patients who have undergone diagnostic testing that localized no more than 2 epileptogenic foci.

    If your patient has not undergone diagnostic testing, search here to find a comprehensive epilepsy center that can evaluate your patient, including determining if the RNS System is right for them.

  • If you are interested in learning more about the RNS® System, you can have an RNS® System professional contact you by filling out the form below:

  • By filling out this form, you are agreeing to the terms of our privacy policy. This form is intended for US residents only.

    By clicking submit, you are agreeing to receive communications from NeuroPace. You can unsubscribe at any time.

    * Required fileds

Share your Story: Terms and conditions

By filling out the form and submitting your story (and/or photograph), you are agreeing to the following:

  1. NeuroPace may review the information and any photographs you provide for potential publication on our website.
  2. If NeuroPace decides to use your story, we will contact you and ask you to sign a release for a version of your story to be used on the NeuroPace website, Facebook, Instagram, Twitter and/or LinkedIn. Unless you sign the release, we will not publish the story, your name, or the photographs you provided.
  3. Regardless of whether we publish your story, we will add your name and e-mail address to the NeuroPace email list to hear from us about product updates, upcoming events and other relevant information. We will not sell your information to third parties. 
  4. Our use of your information is subject to our Privacy Policy, which you can access here.
neuropace logoLogo Header Menu
  • Patients
  • Providers
  • Corporate
  • PDMS
  • nSight
  • Take the Quiz